Use of beta-blockers during aortic aneurysm repair: Bridging the gap between evidence and effective practice

Health Affairs

Volumn 28, Issue 4, 2009, Pages 1199-1209

  Brooke, Benjamin S ^a   Dominici, Francesca ^a   Makary, Martin A ^a   Pronovost, Peter J ^b  

^a Department of Biostatistics ^*

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ABDOMINAL AORTA ANEURYSM; ADULT; ARTICLE; CONTROLLED STUDY; DESCENDING AORTA SURGERY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; SURGICAL MORTALITY; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; AORTIC ANEURYSM, ABDOMINAL; CALIFORNIA; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; PERIOPERATIVE CARE; POISSON DISTRIBUTION; PRACTICE GUIDELINES AS TOPIC;

EID: 67651238330     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.4.1199     Document Type: Article

References (27)

1. D.M. Berwick, "Disseminating Innovations in Health Care," Journal of the American Medical Association 289, no. 15 (2003): 1969-1975;
2. and R.E. Glasgow and K.M. Emmons, "How Can We Increase Translation of Research into Practice? Types of Evidence Needed," Annual Review of Public Health 28 (2007): 413-433.
3. E.A. McGlynn et al., "The Quality of Health Care Delivered to Adults in the United States," New England Journal of Medicine 348, no. 26 (2003): 2635-2645.
4. See the Leapfrog Group for Patient Safety, "About Us," http://www.leapfroggroup.org/about-us (accessed 23 December 2008).
5. Institute of Medicine, Crossing the Quality Chasm: A New Health System for the Twenty-first Century (Washington: National Academies Press, 2001);
6. and J.M. Corrigan, L.T. Kohn, and M.S. Donaldson, eds., To Err Is Human: Building a Safer Health System (Washington: National Academies Press, 2000).
7. J.D. Birkmeyer and J.B. Dimick, "Potential Benefits of the New Leapfrog Standards: Effect of Process and Outcomes Measures," Surgery 135, no. 6 (2004): 569-575.
8. D.T. Mangano et al., "Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery," New England Journal of Medicine 335, no. 23 (1996): 1713-1720;
9. and D.E. Poldermans et al., "The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery," New England Journal of Medicine 341, no. 24 (1999): 1789-1794.
10. Several recent studies have questioned the relative benefit of perioperative beta-blocker use. See POISE Study Group, "Effects of Extended-Release Metoprolol Succinate in Patients Undergoing Non-Cardiac Surgery (POISE Trial): A Randomised Controlled Trial," Lancet 371, no. 9627 (2008): 1839-1847;
11. and P.J. Devereaux et al., "How Strong Is the Evidence for the Use of Perioperative Beta Blockers in Non-Cardiac Surgery? Systematic Review and Meta-Analysis of Randomised Controlled Trials," BMJ 331, no. 7512 (2005): 313-321.
12. For further details, see the Supplemental Technical Appendix, online at http://content.healthaffairs.org/cgi/content/full/28/4/1199/DC1.
13. Ibid.
14. Ibid.
15. Ibid.
16. POISE Study Group, "Effects of Extended-Release Metoprolol";
17. and Devereaux et al., "How Strong Is the Evidence?"
18. L.A. Fleisher et al., "ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery, Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines," Circulation 116, no. 17 (2007): 1971-1996.
19. See Leapfrog Group, "Leapfrog Hospital Survey," 2008, http://www.leapfroggroup.org/for-hospitals/leapfrog-hospital-survey-copy (accessed 23 December 2008).
20. A. Auerbach and L. Goldman, "Assessing and Reducing the Cardiac Risk of Noncardiac Surgery," Circulation 113, no. 10 (2006): 1361-1376.
21. P.K. Lindenauer et al., "Perioperative Beta-Blocker Therapy and Mortality after Major Noncardiac Surgery," New England Journal of Medicine 353, no. 4 (2005): 349-361.
22. POISE Study Group, "Effects of Extended-Release Metoprolol";
23. and Devereaux et al., "How Strong Is the Evidence?"
24. S. Bangalore et al., "Perioperative Beta Blockers in Patients Having Non-Cardiac Surgery: A Meta-Analysis," Lancet 372, no. 9654 (2008): 1962-1976.
25. To learn more about the use of medical checklists, see B.M. Hales and P.J. Pronovost, "The Checklist - A Tool for Error Management and Performance Improvement," Journal of Critical Care 21, no. 3 (2006): 231-235;
26. and A. Gawande, "The Checklist: If Something So Simple Can Transform Intensive Care, What Else Can It Do?" New Yorker, 10 December 2007, 86-101.
27. A. Donabedian, "The Quality of Care: How Can It Be Assessed?" Journal of the American Medical Association 260, no. 12 (1988): 1743-1748.